X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (412) 412
Publication (62) 62
Book Review (33) 33
Book / eBook (14) 14
Conference Proceeding (13) 13
Patent (9) 9
Book Chapter (5) 5
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (255) 255
index medicus (252) 252
male (130) 130
female (127) 127
hematology (120) 120
middle aged (120) 120
aged (105) 105
adult (104) 104
pathology (79) 79
life sciences (78) 78
cancer (73) 73
abridged index medicus (63) 63
immunohistochemistry (63) 63
oncology (61) 61
expression (52) 52
aged, 80 and over (49) 49
lymphomas (48) 48
prognosis (47) 47
non-hodgkins-lymphoma (43) 43
lymphoma (41) 41
antineoplastic combined chemotherapy protocols - therapeutic use (33) 33
immunophenotyping (32) 32
lymphoma, t-cell - pathology (31) 31
chemotherapy (30) 30
lymphoma, t-cell, peripheral - genetics (30) 30
mutation (29) 29
treatment outcome (29) 29
adolescent (27) 27
gene expression profiling (27) 27
rituximab (27) 27
b-cell lymphoma (26) 26
lymphoma, t-cell, peripheral - pathology (26) 26
t cells (26) 26
lymphoma, large b-cell, diffuse - drug therapy (25) 25
non-hodgkin's lymphomas (25) 25
immunology (24) 24
epstein-barr-virus (23) 23
features (23) 23
gene expression regulation, neoplastic (23) 23
[ sdv.bbm ] life sciences [q-bio]/biochemistry, molecular biology (22) 22
retrospective studies (22) 22
survival (22) 22
phenotype (21) 21
biochemistry, molecular biology (20) 20
biomarkers, tumor - metabolism (20) 20
classification (20) 20
animals (19) 19
antineoplastic combined chemotherapy protocols - administration & dosage (19) 19
diagnosis, differential (19) 19
disease-free survival (19) 19
hemic and lymphatic diseases (19) 19
leukemia (19) 19
surgery (19) 19
biopsy (18) 18
disease (18) 18
herpesvirus 4, human - isolation & purification (18) 18
lymphoma, large b-cell, diffuse - mortality (18) 18
young adult (18) 18
follicular lymphoma (17) 17
lymphoma, t-cell, peripheral - metabolism (17) 17
survival analysis (17) 17
article (16) 16
cyclophosphamide - administration & dosage (16) 16
doxorubicin - administration & dosage (16) 16
follow-up studies (16) 16
gene-expression (16) 16
genetic aspects (16) 16
in situ hybridization, fluorescence (16) 16
lymphoma, b-cell - pathology (16) 16
lymphoma, t-cell, peripheral - diagnosis (16) 16
lymphoproliferative disorders (16) 16
risk factors (16) 16
elderly-patients (15) 15
gene (15) 15
immunoblastic lymphadenopathy - pathology (15) 15
killer cells, natural - pathology (15) 15
lymphoma, large b-cell, diffuse - pathology (15) 15
lymphoma, t-cell - genetics (15) 15
mutations (15) 15
prednisone - administration & dosage (15) 15
research (15) 15
transplantation (15) 15
differentiation (14) 14
lymphocytes (14) 14
lymphoma, b-cell - genetics (14) 14
t-cell lymphoma (14) 14
t-lymphocytes, helper-inducer - pathology (14) 14
angioimmunoblastic t-cell lymphoma (13) 13
antibodies, monoclonal, murine-derived (13) 13
apoptosis (13) 13
cell biology (13) 13
gastroenterology & hepatology (13) 13
in situ hybridization (13) 13
lymph nodes - pathology (13) 13
peripheral t-cell lymphoma (13) 13
reverse transcriptase polymerase chain reaction (13) 13
vincristine - administration & dosage (13) 13
analysis (12) 12
biomarkers, tumor - genetics (12) 12
gene expression (12) 12
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (10) 10
Art - Library use only (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Victoria University CRRS - Library use only (2) 2
Art - Stacks (1) 1
Robarts - Searching (1) 1
St. Michael's College (John M. Kelly) - Sable (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 460 - 468
Summary Background Diffuse large B-cell lymphoma is a common cancer in elderly patients. Although treatment has been standardised in younger patients, no... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE RITUXIMAB | COLONY-STIMULATING FACTOR | PROGNOSTIC-FACTORS | RESPONSE CRITERIA | ONCOLOGY | AGGRESSIVE LYMPHOMAS | MALIGNANT-LYMPHOMAS | NON-HODGKINS-LYMPHOMA | COMPREHENSIVE GERIATRIC ASSESSMENT | DETUDE-DES-LYMPHOMES | CHOP CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Aged, 80 and over | Vincristine - administration & dosage | Female | France | Odds Ratio | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Risk Factors | Rituximab | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Analysis of Variance | Belgium | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - adverse effects | Doxorubicin - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Oncology, Experimental | Aged patients | Product development | Prednisone | Lymphomas | Research | Cancer | Toxicity | Albumin | Clinical trials | Multivariate analysis | Doxorubicin | Survival | Vincristine | Side effects | Motivation | Age | rituximab | B-cell lymphoma | Geriatrics | Neutropenia | Index Medicus
Journal Article
ANNALES DE PATHOLOGIE, ISSN 0242-6498, 04/2015, Volume 35, Issue 2, pp. 127 - 128
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 31, pp. 4079 - 4087
Purpose To evaluate the prognostic value of the cell of origin (COO) in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBLC), prospectively... 
MOLECULAR SUBTYPES | SURVIVAL | ONCOLOGY | RISK STRATIFICATION | R-CHOP | RITUXIMAB | NON-HODGKINS-LYMPHOMAS | CLASSIFICATION | TISSUE MICROARRAY | ELDERLY-PATIENTS | EXPRESSION | Immunohistochemistry | Multivariate Analysis | Predictive Value of Tests | Recurrence | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Gene Expression Regulation, Neoplastic | Male | Gene Expression Profiling | Antigens, CD20 - blood | Cisplatin - administration & dosage | Multicenter Studies as Topic | Microarray Analysis | Lymphoma, Large B-Cell, Diffuse - chemistry | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Neoplasm Proteins - genetics | Dexamethasone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Biomarkers, Tumor - analysis | Risk Factors | Proportional Hazards Models | Carboplatin - administration & dosage | Rituximab | Etoposide - administration & dosage | In Situ Hybridization, Fluorescence | Germinal Center - pathology | Cytarabine - administration & dosage | Randomized Controlled Trials as Topic | Disease-Free Survival | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasm, Residual - drug therapy | Neoplasm Proteins - analysis | Aged | Biomarkers, Tumor - genetics | Salvage Therapy - methods | Index Medicus | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Annales de Pathologie, ISSN 0242-6498, 04/2015, Volume 35, Issue 2, pp. 127 - 128
Journal Article
Blood, ISSN 0006-4971, 05/2014, Volume 123, Issue 19, pp. 2909 - 2910
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 4, pp. 329 - 335
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2002, Volume 346, Issue 4, pp. 235 - 242
Journal Article
Journal Article
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2018, Volume 18, pp. S95 - S96
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 7, pp. 1466 - 1469
Inactivating mutations of the Ten-Eleven Translocation 2 (TET2) gene were first identified in myeloid malignancies and more recently in peripheral T-cell... 
TRANSFORMATION | IDH2 MUTATIONS | FREQUENT | 5-METHYLCYTOSINE | GENES | LEADS | MYELOID MALIGNANCIES | DIFFERENTIATION | PROTEINS | HEMATOLOGY | EXPRESSION
Journal Article
Leukemia, ISSN 0887-6924, 2012, Volume 26, Issue 5, pp. 1053 - 1063
Journal Article